Pennant Group Inc Stock Price, News & Analysis

The Pennant Group (NASDAQ: PNTG) has announced its plans to release third quarter 2024 financial results on November 6, 2024. The company will host a live webcast on November 7, 2024, at 10:00 a.m. Mountain Time to discuss the results. Investors can access the webcast through the Investor Relations section of Pennant's website. The recorded webcast will be available for replay until November 6, 2025.

Pennant Group is a holding company operating 122 home health and hospice agencies and 54 senior living communities across 13 states. These healthcare services are provided through independent operating subsidiaries, each with its own management and assets.

The Pennant Group (NASDAQ: PNTG) announced the pricing of an underwritten public offering of 3,500,000 shares of its common stock at $31.00 per share, aiming to raise $108.5 million before deducting underwriting discounts, commissions, and expenses. The underwriters have a 30-day option to purchase an additional 525,000 shares. The company plans to use the net proceeds to repay outstanding debt under its revolving credit facility and for general corporate purposes. The offering is expected to close around October 4, 2024, subject to customary conditions. Citigroup and Truist Securities are the lead book-running managers, with Wells Fargo Securities and RBC Capital Markets as joint book-running managers. Oppenheimer & Co. and Stephens Inc. are co-managers. The offering is being made under an effective shelf registration statement filed with the SEC. A preliminary prospectus supplement was filed on September 30, 2024, and the final prospectus supplement will be filed with the SEC.

The Pennant Group (NASDAQ: PNTG) has announced a public offering of 3,500,000 shares of common stock. The company plans to grant underwriters a 30-day option to purchase up to 525,000 additional shares. Proceeds will be used to repay outstanding debt under the company's revolving credit facility, with any remaining funds allocated for general corporate purposes.

Citigroup and Truist Securities are lead book-running managers, while Wells Fargo Securities and RBC Capital Markets are joint book-running managers. Oppenheimer & Co. and Stephens Inc. are acting as co-managers. The offering is being made pursuant to the company's effective shelf registration statement filed with the SEC.

The Pennant Group (NASDAQ: PNTG) reported strong Q2 2024 results, with total revenue increasing 27.6% to $168.7 million and net income rising 103.4% to $5.7 million. Key highlights include:

- Home Health and Hospice segment revenue up 31.9% to $125.3 million
- Senior Living Services segment revenue increased 16.6% to $43.4 million
- Total home health admissions grew 35.4% to 14,140
- Hospice average daily census rose 29.1% to 3,220

The company updated its 2024 guidance, projecting total revenue between $654.0 million and $694.5 million, and adjusted earnings per diluted share between $0.89 and $0.95. Pennant's CEO attributed the strong performance to mature operations and robust acquisition activity.

The Pennant Group (NASDAQ: PNTG) has completed the acquisition of Signature Healthcare at Home's Washington and Idaho assets. This marks the first phase of a larger acquisition, with Signature's Oregon business set to close on January 1, 2025. The acquisition strengthens Pennant's presence in Idaho and expands its footprint in Washington, a critical certificate of need state.

Pennant's CEO, Brent Guerisoli, highlighted the acquisition as a significant milestone in the company's investment in the Pacific Northwest. The company plans to implement its unique operating model, innovative technology, and best practices to enhance the quality of care in the acquired operations. This strategic move is expected to complement Pennant's existing operations and leverage its high-performing leaders in the region.

The Pennant Group (NASDAQ: PNTG) has announced a significant expansion of its credit facility, increasing it by $100 million to reach a total of $250 million. This new facility, arranged by Truist Securities and supported by a lending consortium, will expire on July 31, 2029. The company plans to use the proceeds to refinance existing borrowings, fund acquisitions, cover working capital needs, and support other business purposes.

CEO Brent Guerisoli emphasized that this amended facility strengthens Pennant's balance sheet and, combined with strong operating cash flow, provides substantial resources for future growth. CFO Lynette Walbom expressed appreciation for the continued support of their banking partners and the confidence shown by new lenders joining the consortium.

The Pennant Group (NASDAQ: PNTG) has announced its plans to release second quarter 2024 financial results on August 6, 2024. The company will host a live webcast on August 7, 2024, at 10:00 a.m. Mountain Time for management to discuss the results. Pennant operates 118 home health and hospice agencies and 54 senior living communities across 13 states through independent subsidiaries. Investors can access the webcast and financial information on the company's investor relations website. The recorded webcast will be available for replay until August 6, 2025.

The Pennant Group (NASDAQ: PNTG) announced an agreement to purchase assets from Signature Healthcare at Home for $80 million. The acquisition, covering locations in Oregon, Washington, and Idaho, is expected to bolster Pennant's presence in the Pacific Northwest. Signature Healthcare's assets include over 650 staff, $78 million in annual revenue, 12,000 home health admissions, and a 300 daily hospice census. The purchases are set to close on August 1, 2024, and January 1, 2025, pending customary conditions and regulatory approvals. This acquisition aligns with Pennant's growth strategy and aims to enhance operational efficiency and leadership development within the acquired regions.

The Pennant Group (NASDAQ: PNTG) has entered into a management and consulting services agreement with Hartford HealthCare at Home (HHCAH) to provide operational support. HHCAH, a part of Hartford HealthCare, serves Connecticut with over 1,000 employees and 33,000 home health admissions annually. Pennant will offer operational leadership through its service center, which employs over 300 individuals. The collaboration aims to enhance in-home care services, improve clinical outcomes, and create jobs in Connecticut. This partnership reflects Hartford's commitment to expanding home-based care as a vital part of healthcare delivery.